Learn what PT-141 (bremelanotide) is, its FDA-approved HSDD indication, melanocortin mechanism, limitations, side effects and common misconceptions.
Review tesamorelin clinical trial data for visceral adipose tissue, its FDA-approved indication, limitations, glucose considerations and common misconceptions.
What do we really know about Semax and Selank? Review proposed mechanisms, cognitive and anxiety claims, evidence gaps and FDA safety considerations.
Compare subcutaneous NAD+ and IV NAD+ therapy, including delivery differences, evidence limitations, practical tradeoffs and questions to ask a clinician.